U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages | Contact Us

Start Over | Back to Previous Screen

Sodium Acetate Injection
Status: Currently in Shortage
»Date first posted: 02/03/2016
»Therapeutic Categories: Endocrinology/Metabolism; Gastroenterology; Pediatric; Total Parenteral Nutrition

Expand all

Fresenius Kabi USA, LLC (Reverified 06/05/2024)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Injection, 4 meq/100 mL (NDC 63323-032-00) Available Check wholesalers for inventory

Hospira, Inc., a Pfizer Company (Revised 06/13/2024)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Injection, 100 mEq/50 mL (2 mEq/mL) (NDC 0409-3299-05) Limited Availability Limited Supply Available. Next Delivery: June 2024; Estimated Recovery: June 2024 Demand increase for the drug
Injection, 200 mEq/100 mL (2 mEq/mL) (NDC 0409-3299-06) Limited Availability Limited Supply Available. Next Delivery: June 2024; Estimated Recovery: August 2024 Delay in shipping of the drug
Injection, 40 mEq/20 mL (2 mEq/mL) (NDC 0409-7299-73) Unavailable Next Delivery and Estimated Recovery: July 2024 Demand increase for the drug
Injection, 200 mEq/100 mL (2 mEq/mL) (NDC 0409-3299-25) Unavailable Next Delivery and Estimated Recovery: November 2024 Demand increase for the drug
Injection, 100 mEq/50 mL (2 mEq/mL) (NDC 0409-3299-26) Unavailable Next Delivery and Estimated Recovery: December 2024 Demand increase for the drug
Injection, 40 mEq/20 mL (2 mEq/mL) (NDC 0409-7299-25) Unavailable Next Delivery and Estimated Recovery: July 2024 Demand increase for the drug

Milla Pharmaceuticals (Revised 06/06/2024)

Company Contact Information:
833-251-8463

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Injection, 400 mEq/100mL (4 mEq/mL) (NDC 69784-232-01) Available
Injection, 40 mEq/20mL (2 mEq/mL) (NDC 69784-229-10) Available
Injection, 100 mEq/50mL (2 mEq/mL) (NDC 69784-230-10) Available
Injection, 200 mEq/100mL (2 mEq/mL) (NDC 69784-231-10) Available
Back to Top